ID RCN1_HUMAN Reviewed; 331 AA. AC Q15293; B7Z1M1; D3DR00; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1997, sequence version 1. DT 24-JAN-2024, entry version 203. DE RecName: Full=Reticulocalbin-1; DE Flags: Precursor; GN Name=RCN1; Synonyms=RCN; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=8586628; DOI=10.1093/oxfordjournals.jbchem.a124815; RA Ozawa M.; RT "Cloning of a human homologue of mouse reticulocalbin reveals conservation RT of structural domains in the novel endoplasmic reticulum resident Ca(2+)- RT binding protein with multiple EF-hand motifs."; RL J. Biochem. 117:1113-1119(1995). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Cerebellum; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16554811; DOI=10.1038/nature04632; RA Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., RA Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., RA Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G., RA Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C., RA Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A., RA Hattori M., Rogers J., Lander E.S., Sakaki Y.; RT "Human chromosome 11 DNA sequence and analysis including novel gene RT identification."; RL Nature 440:497-500(2006). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Ovary; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-53. RC TISSUE=Liver; RX PubMed=19159218; DOI=10.1021/pr8008012; RA Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; RT "Glycoproteomics analysis of human liver tissue by combination of multiple RT enzyme digestion and hydrazide chemistry."; RL J. Proteome Res. 8:651-661(2009). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-76, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55; THR-76 AND SER-80, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [10] RP PHOSPHORYLATION AT SER-80. RX PubMed=26091039; DOI=10.1016/j.cell.2015.05.028; RA Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J., RA Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N., RA Pinna L.A., Pagliarini D.J., Dixon J.E.; RT "A single kinase generates the majority of the secreted phosphoproteome."; RL Cell 161:1619-1632(2015). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25944712; DOI=10.1002/pmic.201400617; RA Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D., RA Lane L., Bairoch A., Van Dorsselaer A., Carapito C.; RT "N-terminome analysis of the human mitochondrial proteome."; RL Proteomics 15:2519-2524(2015). RN [12] RP GLYCOSYLATION. RX PubMed=28512129; DOI=10.1074/jbc.m117.794487; RA Larsen I.S.B., Narimatsu Y., Joshi H.J., Yang Z., Harrison O.J., Brasch J., RA Shapiro L., Honig B., Vakhrushev S.Y., Clausen H., Halim A.; RT "Mammalian O-mannosylation of cadherins and plexins is independent of RT protein O-mannosyltransferases 1 and 2."; RL J. Biol. Chem. 292:11586-11598(2017). RN [13] RP VARIANT [LARGE SCALE ANALYSIS] LEU-117. RX PubMed=16959974; DOI=10.1126/science.1133427; RA Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., RA Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., RA Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V., RA Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., RA Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., RA Velculescu V.E.; RT "The consensus coding sequences of human breast and colorectal cancers."; RL Science 314:268-274(2006). CC -!- FUNCTION: May regulate calcium-dependent activities in the endoplasmic CC reticulum lumen or post-ER compartment. CC -!- INTERACTION: CC Q15293; Q12797-6: ASPH; NbExp=3; IntAct=EBI-948278, EBI-12092171; CC Q15293; Q8N5M1: ATPAF2; NbExp=3; IntAct=EBI-948278, EBI-1166928; CC Q15293; P54253: ATXN1; NbExp=9; IntAct=EBI-948278, EBI-930964; CC Q15293; P46379-2: BAG6; NbExp=3; IntAct=EBI-948278, EBI-10988864; CC Q15293; O15182: CETN3; NbExp=5; IntAct=EBI-948278, EBI-712959; CC Q15293; Q8TEB1: DCAF11; NbExp=5; IntAct=EBI-948278, EBI-2213388; CC Q15293; O75190-2: DNAJB6; NbExp=3; IntAct=EBI-948278, EBI-12593112; CC Q15293; Q5JVL4: EFHC1; NbExp=3; IntAct=EBI-948278, EBI-743105; CC Q15293; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-948278, EBI-744099; CC Q15293; Q9BQ89: FAM110A; NbExp=3; IntAct=EBI-948278, EBI-1752811; CC Q15293; O95257: GADD45G; NbExp=3; IntAct=EBI-948278, EBI-448202; CC Q15293; O43681: GET3; NbExp=5; IntAct=EBI-948278, EBI-2515857; CC Q15293; Q969Y2: GTPBP3; NbExp=3; IntAct=EBI-948278, EBI-740290; CC Q15293; A0A024R8L2: hCG_1987119; NbExp=3; IntAct=EBI-948278, EBI-14103818; CC Q15293; P42858: HTT; NbExp=3; IntAct=EBI-948278, EBI-466029; CC Q15293; O14901: KLF11; NbExp=3; IntAct=EBI-948278, EBI-948266; CC Q15293; P25800: LMO1; NbExp=3; IntAct=EBI-948278, EBI-8639312; CC Q15293; P25791-3: LMO2; NbExp=3; IntAct=EBI-948278, EBI-11959475; CC Q15293; Q8TAP4-4: LMO3; NbExp=3; IntAct=EBI-948278, EBI-11742507; CC Q15293; P61968: LMO4; NbExp=3; IntAct=EBI-948278, EBI-2798728; CC Q15293; O43765: SGTA; NbExp=3; IntAct=EBI-948278, EBI-347996; CC Q15293; Q96EQ0: SGTB; NbExp=3; IntAct=EBI-948278, EBI-744081; CC Q15293; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-948278, EBI-5235340; CC Q15293; P51687: SUOX; NbExp=3; IntAct=EBI-948278, EBI-3921347; CC Q15293; Q86VK4-3: ZNF410; NbExp=3; IntAct=EBI-948278, EBI-11741890; CC Q15293; PRO_0000449619 [P0DTD1]: rep; Xeno; NbExp=2; IntAct=EBI-948278, EBI-25475847; CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q15293-1; Sequence=Displayed; CC Name=2; CC IsoId=Q15293-2; Sequence=VSP_055511; CC -!- PTM: O-glycosylated. O-mannosylated by POMT1 and POMT2 and elongated by CC POMGNT1. {ECO:0000269|PubMed:28512129}. CC -!- MISCELLANEOUS: This protein has four functional calcium-binding sites; CC potential sites II and VI have lost affinity for calcium. CC {ECO:0000250}. CC -!- SIMILARITY: Belongs to the CREC family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D42073; BAA07670.1; -; mRNA. DR EMBL; AK293652; BAH11557.1; -; mRNA. DR EMBL; AL035078; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL049635; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL078612; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL138970; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; Z95332; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471064; EAW68227.1; -; Genomic_DNA. DR EMBL; CH471064; EAW68228.1; -; Genomic_DNA. DR EMBL; BC010120; AAH10120.1; -; mRNA. DR CCDS; CCDS7876.1; -. [Q15293-1] DR PIR; JC4173; JC4173. DR RefSeq; NP_002892.1; NM_002901.2. [Q15293-1] DR AlphaFoldDB; Q15293; -. DR BioGRID; 111887; 275. DR ELM; Q15293; -. DR IntAct; Q15293; 125. DR MINT; Q15293; -. DR STRING; 9606.ENSP00000054950; -. DR GlyConnect; 1712; 21 N-Linked glycans (1 site). DR GlyCosmos; Q15293; 2 sites, 22 glycans. DR GlyGen; Q15293; 5 sites, 28 N-linked glycans (1 site), 2 O-linked glycans (4 sites). DR iPTMnet; Q15293; -. DR MetOSite; Q15293; -. DR PhosphoSitePlus; Q15293; -. DR BioMuta; RCN1; -. DR DMDM; 2493462; -. DR CPTAC; CPTAC-266; -. DR CPTAC; CPTAC-267; -. DR EPD; Q15293; -. DR jPOST; Q15293; -. DR MassIVE; Q15293; -. DR MaxQB; Q15293; -. DR PaxDb; 9606-ENSP00000054950; -. DR PeptideAtlas; Q15293; -. DR ProteomicsDB; 60519; -. [Q15293-1] DR ProteomicsDB; 6347; -. DR Pumba; Q15293; -. DR TopDownProteomics; Q15293-1; -. [Q15293-1] DR Antibodypedia; 25609; 152 antibodies from 23 providers. DR DNASU; 5954; -. DR Ensembl; ENST00000054950.4; ENSP00000054950.4; ENSG00000049449.10. [Q15293-1] DR GeneID; 5954; -. DR KEGG; hsa:5954; -. DR MANE-Select; ENST00000054950.4; ENSP00000054950.4; NM_002901.4; NP_002892.1. DR UCSC; uc058acp.1; human. [Q15293-1] DR AGR; HGNC:9934; -. DR CTD; 5954; -. DR DisGeNET; 5954; -. DR GeneCards; RCN1; -. DR HGNC; HGNC:9934; RCN1. DR HPA; ENSG00000049449; Tissue enriched (epididymis). DR MIM; 602735; gene. DR neXtProt; NX_Q15293; -. DR OpenTargets; ENSG00000049449; -. DR PharmGKB; PA34303; -. DR VEuPathDB; HostDB:ENSG00000049449; -. DR eggNOG; KOG4223; Eukaryota. DR GeneTree; ENSGT01010000222360; -. DR HOGENOM; CLU_044718_0_1_1; -. DR InParanoid; Q15293; -. DR OMA; DRPGFQY; -. DR OrthoDB; 4490703at2759; -. DR PhylomeDB; Q15293; -. DR TreeFam; TF314849; -. DR PathwayCommons; Q15293; -. DR Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs). DR Reactome; R-HSA-8957275; Post-translational protein phosphorylation. DR SignaLink; Q15293; -. DR BioGRID-ORCS; 5954; 35 hits in 1149 CRISPR screens. DR ChiTaRS; RCN1; human. DR GeneWiki; RCN1; -. DR GenomeRNAi; 5954; -. DR Pharos; Q15293; Tbio. DR PRO; PR:Q15293; -. DR Proteomes; UP000005640; Chromosome 11. DR RNAct; Q15293; Protein. DR Bgee; ENSG00000049449; Expressed in corpus epididymis and 204 other cell types or tissues. DR ExpressionAtlas; Q15293; baseline and differential. DR GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA. DR GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome. DR GO; GO:0005509; F:calcium ion binding; IBA:GO_Central. DR GO; GO:0043010; P:camera-type eye development; IEA:Ensembl. DR GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl. DR CDD; cd16229; EFh_CREC_RCN1; 1. DR Gene3D; 1.10.238.10; EF-hand; 3. DR InterPro; IPR011992; EF-hand-dom_pair. DR InterPro; IPR018247; EF_Hand_1_Ca_BS. DR InterPro; IPR002048; EF_hand_dom. DR InterPro; IPR027241; Rcn1. DR PANTHER; PTHR10827; RETICULOCALBIN; 1. DR PANTHER; PTHR10827:SF17; RETICULOCALBIN-1; 1. DR Pfam; PF13202; EF-hand_5; 2. DR Pfam; PF13499; EF-hand_7; 1. DR SMART; SM00054; EFh; 3. DR SUPFAM; SSF47473; EF-hand; 2. DR PROSITE; PS00018; EF_HAND_1; 4. DR PROSITE; PS50222; EF_HAND_2; 6. DR PROSITE; PS00014; ER_TARGET; 1. DR Genevisible; Q15293; HS. PE 1: Evidence at protein level; KW Alternative splicing; Calcium; Endoplasmic reticulum; Glycoprotein; KW Metal-binding; Phosphoprotein; Reference proteome; Repeat; Signal. FT SIGNAL 1..29 FT /evidence="ECO:0000255" FT CHAIN 30..331 FT /note="Reticulocalbin-1" FT /id="PRO_0000004145" FT DOMAIN 79..114 FT /note="EF-hand 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 115..150 FT /note="EF-hand 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 166..201 FT /note="EF-hand 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 203..238 FT /note="EF-hand 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 244..279 FT /note="EF-hand 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 280..315 FT /note="EF-hand 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT MOTIF 328..331 FT /note="Prevents secretion from ER" FT BINDING 92 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 94 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 96 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 103 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 128 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 130 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 132 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 134 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 139 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 179 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000305" FT BINDING 181 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000305" FT BINDING 183 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000305" FT BINDING 185 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000305" FT BINDING 190 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000305" FT BINDING 216 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 218 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 220 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 227 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 257 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 259 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 261 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 263 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 268 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 293 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="6" FT /evidence="ECO:0000305" FT BINDING 295 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="6" FT /evidence="ECO:0000305" FT BINDING 297 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="6" FT /evidence="ECO:0000305" FT BINDING 299 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="6" FT /evidence="ECO:0000305" FT BINDING 304 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="6" FT /evidence="ECO:0000305" FT MOD_RES 55 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:24275569" FT MOD_RES 76 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:24275569" FT MOD_RES 80 FT /note="Phosphoserine; by FAM20C" FT /evidence="ECO:0000269|PubMed:26091039, FT ECO:0007744|PubMed:24275569" FT CARBOHYD 53 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19159218" FT VAR_SEQ 1..85 FT /note="MARGGRGRRLGLALGLLLALVLAPRVLRAKPTVRKERVVRPDSELGERPPED FT NQSFQYDHEAFLGKEDSKTFDQLTPDESKERLG -> MTGGEGPLPTAKQATCSPPSSR FT ERNPRRRGSRPR (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_055511" FT VARIANT 73 FT /note="D -> Y (in dbSNP:rs1804281)" FT /id="VAR_011965" FT VARIANT 117 FT /note="F -> L (in a colorectal cancer sample; somatic FT mutation)" FT /evidence="ECO:0000269|PubMed:16959974" FT /id="VAR_035460" SQ SEQUENCE 331 AA; 38890 MW; 608AAD536963F789 CRC64; MARGGRGRRL GLALGLLLAL VLAPRVLRAK PTVRKERVVR PDSELGERPP EDNQSFQYDH EAFLGKEDSK TFDQLTPDES KERLGKIVDR IDNDGDGFVT TEELKTWIKR VQKRYIFDNV AKVWKDYDRD KDDKISWEEY KQATYGYYLG NPAEFHDSSD HHTFKKMLPR DERRFKAADL NGDLTATREE FTAFLHPEEF EHMKEIVVLE TLEDIDKNGD GFVDQDEYIA DMFSHEENGP EPDWVLSERE QFNEFRDLNK DGKLDKDEIR HWILPQDYDH AQAEARHLVY ESDKNKDEKL TKEEILENWN MFVGSQATNY GEDLTKNHDE L //